Drug Information Association Logo
« Back to Listing

Career Planning and Limitations for Mid- to Upper-Level Project Managers

Track:
Project/Portfolio Management and Strategic Planning

Day & Time:
June 18, 10:30AM - 12:00PM (Pacific Standard Time)

Session Number:
330

Room Number:
5A

Level:
Advanced

Type:
Forum

Title:
Career Planning and Limitations for Mid- to Upper-Level Project Managers

Chair(s):
Mark A. Kryah, PMP
Sr. Advisor, Pharmaceutical Project Management
Eli Lilly and Company, United States

Description:
If you have been managing R&D drug development projects for several years, what options do you have for further advancement or to continue to develop depth and expertise? If you feel that you have reached a limit or have plateaued, this forum will provide a variety of perspectives to consider as you evaluate what is next in your career.

Learning Objective(s):
Discuss options to consider when evaluating a career path in R&D project management; Identify one or two tangible action steps in decision-making regarding continuing a career in R&D project management.

Presentation(s) & Speaker(s):
Panelist
Michele C. Livesey, MBA
Drug Development Strategy and Execution Consultant
Livesey Consulting, United States

Panelist
Tina Rarick, MBA
President
Angus Bio Consulting, LLC, United States

Panelist
Ben Quartley, PhD
Senior Director
Covance Inc., United Kingdom